The COVID-19 vaccine candidates developed by Moderna Inc. and BioNTech and Pfizer Inc. will require strict standards for cooling, and that may hinder how they are distributed to the hundreds of millions of Americans who expect to receive them. Shares of Modern MRNA, -3.54% were 3.6% lower in trading on …
Read More »The COVID-19 vaccine candidates from Moderna and Pfizer need ultra-low temperatures, raising questions about storage, distribution
